Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Emily Hayes

    News

    Amgen Rethinks Ganitumab After Failure in Pancreatic Cancer

    Author:
    Emily Hayes
    Publish date: August 14, 2012

    • Read More

    News

    Second Lorcaserin Review to Address Risk/Benefit Tradeoffs

    Author:
    Emily Hayes
    Publish date: March 21, 2012

    • Read More

    News

    Picato Gel Approved to Treat Actinic Keratoses

    Author:
    Emily Hayes
    Publish date: January 30, 2012

    • Read More

    News

    Nonpsychiatric Prescribing Fuels Rise in Antidepressant Use

    Author:
    Emily Hayes
    Publish date: August 5, 2011

    • Read More

    News

    Secondary Cancers Resurface in Lenalidomide Maintenance Trial Data

    Author:
    Emily Hayes
    Publish date: May 6, 2011

    • Read More

    News

    First-Line Tarceva May Benefit NSCLC With EGFR Mutation

    Author:
    Emily Hayes
    “the Pink Sheet”
    Publish date: March 1, 2011

    • Read More

    News

    First-Line Tarceva May Benefit NSCLC With EGFR Mutation

    Author:
    Emily Hayes
    “the Pink Sheet”
    Publish date: March 1, 2011

    • Read More

    News

    First-Line Tarceva May Benefit NSCLC With EGFR Mutation

    Author:
    Emily Hayes
    “the Pink Sheet”
    Publish date: March 1, 2011

    • Read More

    News

    Afrezza Receives FDA Complete Response Letter

    Author:
    Emily Hayes
    Publish date: February 15, 2011

    • Read More

    News

    Early Analysis Supports Erlotinib for First-Line Treatment of NSCLC With EGFR Mutation

    Author:
    Emily Hayes
    Publish date: January 31, 2011

    • Read More

    News

    Early Analysis Supports Erlotinib for First-Line Treatment of NSCLC With EGFR Mutation

    Author:
    Emily Hayes
    Publish date: January 31, 2011

    • Read More

    News

    Afrezza Receives FDA Complete Response Letter

    Author:
    Emily Hayes
    Publish date: January 20, 2011

    • Read More

    News

    Afrezza Receives FDA Complete Response Letter

    Author:
    Emily Hayes
    Publish date: January 20, 2011

    • Read More

    News

    FDA Wants Controlled tQT Study of Long-Acting Exenatide

    Author:
    Emily Hayes
    Publish date: November 15, 2010

    • Read More

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery